EMEA-001780-PIP01-15
Key facts
| Active substance |
|
| Therapeutic area |
Neonatology-Paediatric Intensive Care
|
| Decision number |
P/0363/2016
|
| PIP number |
EMEA-001780-PIP01-15
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of respiratory distress syndrome
|
| Route(s) of administration |
Endotracheopulmonary use
|
| Contact for public enquiries |
Chiesi Farmaceutici SpA
|
| Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|